Literature DB >> 8720606

Prolonged QT interval as a predictor of mortality in diabetic nephropathy.

P T Sawicki1, R Dähne, R Bender, M Berger.   

Abstract

Patients with diabetic nephropathy face an increased risk of dying due to cardiac causes. The aim of this follow-up trial was to describe the association between the length of the QT interval, as a marker of myocardial electrical stability, and the risk of death in insulin-dependent (IDDM) diabetic patients with overt diabetic nephropathy. A consecutive sample of 85 IDDM patients with overt diabetic nephropathy (i.e. persistent proteinuria > or = 500 mg/24 h) were followed-up until death or for a period of 5-13 years. QT intervals were measured once at baseline in a 12-lead ECG and corrected for heart rate (QTc). During the follow-up period 33 patients (39%) died. In the Cox proportional hazards model independent predictors of death were age (p = 0.0007), the length of the maximum QTc period (p = 0.0049), presence of autonomic neuropathy (p = 0.0068), diabetes duration (p = 0.0163) and RR variation (p = 0.0395). In conclusion, in nephropathic IDDM patients QT prolongation is associated with an increased mortality risk which is independent of the presence of autonomic neuropathy. Further studies are needed to determine whether this risk might be reduced by therapeutic interventions.

Entities:  

Mesh:

Year:  1996        PMID: 8720606     DOI: 10.1007/BF00400416

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  27 in total

1.  Effects of metoprolol on heart rate variability in survivors of acute myocardial infarction.

Authors:  H Mølgaard; H Mickley; P Pless; P Bjerregaard; M Møller
Journal:  Am J Cardiol       Date:  1993-06-01       Impact factor: 2.778

2.  Cardiorespiratory arrest and diabetic autonomic neuropathy.

Authors:  M M Page; P J Watkins
Journal:  Lancet       Date:  1978-01-07       Impact factor: 79.321

3.  Influence of the autonomic nervous system on the Q-T interval in man.

Authors:  K F Browne; D P Zipes; J J Heger; E N Prystowsky
Journal:  Am J Cardiol       Date:  1982-11       Impact factor: 2.778

4.  Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death?

Authors:  F Bellavere; M Ferri; L Guarini; G Bax; A Piccoli; C Cardone; D Fedele
Journal:  Br Heart J       Date:  1988-03

5.  Prognosis in diabetic nephropathy.

Authors:  H H Parving; E Hommel
Journal:  BMJ       Date:  1989-07-22

6.  Association of 24-h cardiac parasympathetic activity and degree of nephropathy in IDDM patients.

Authors:  H Mølgaard; P D Christensen; K E Sørensen; C K Christensen; C E Mogensen
Journal:  Diabetes       Date:  1992-07       Impact factor: 9.461

7.  Autonomic neuropathy, QT interval lengthening, and unexpected deaths in male diabetic patients.

Authors:  D J Ewing; O Boland; J M Neilson; C G Cho; B F Clarke
Journal:  Diabetologia       Date:  1991-03       Impact factor: 10.122

8.  Influence of heart rate and inhibition of autonomic tone on the QT interval.

Authors:  S Ahnve; H Vallin
Journal:  Circulation       Date:  1982-03       Impact factor: 29.690

9.  QT dispersion and sudden unexpected death in chronic heart failure.

Authors:  C S Barr; A Naas; M Freeman; C C Lang; A D Struthers
Journal:  Lancet       Date:  1994-02-05       Impact factor: 79.321

Review 10.  Diabetic patients and beta-blockers after acute myocardial infarction.

Authors:  J Kjekshus; E Gilpin; G Cali; A R Blackey; H Henning; J Ross
Journal:  Eur Heart J       Date:  1990-01       Impact factor: 29.983

View more
  17 in total

1.  Electrocardiographic repolarization abnormalities in familial dysautonomia: an indicator of cardiac autonomic dysfunction.

Authors:  J S Glickstein; F B Axelrod; D Friedman
Journal:  Clin Auton Res       Date:  1999-04       Impact factor: 4.435

Review 2.  Antipsychotic agents and QT changes.

Authors:  R Welch; P Chue
Journal:  J Psychiatry Neurosci       Date:  2000-03       Impact factor: 6.186

3.  Lung function, percent emphysema, and QT duration: The Multi-Ethnic Study of Atherosclerosis (MESA) lung study.

Authors:  Hilary F Armstrong; Gina S Lovasi; Elsayed Z Soliman; Susan R Heckbert; Bruce M Psaty; John H M Austin; Jerry A Krishnan; Eric A Hoffman; Craig Johnson; Matthew J Budoff; Karol E Watson; R Graham Barr
Journal:  Respir Med       Date:  2016-12-08       Impact factor: 3.415

4.  Defective calcium inactivation causes long QT in obese insulin-resistant rat.

Authors:  Yen-Chang Lin; Jianying Huang; Hong Kan; Vincent Castranova; Jefferson C Frisbee; Han-Gang Yu
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-12-23       Impact factor: 4.733

5.  Autonomic neuropathy and QT interval in hemodialysed patients.

Authors:  Simona Maule; Massimo Veglio; Fabio Mecca; Chiara Calvo; Guido Martina; Martino Marangella; Roberto Quadri; Paolo Cavallo Perin
Journal:  Clin Auton Res       Date:  2004-08       Impact factor: 4.435

Review 6.  Ziprasidone in the management of schizophrenia : the QT interval issue in context.

Authors:  David Taylor
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 7.  Diabetic neuropathy: mechanisms to management.

Authors:  James L Edwards; Andrea M Vincent; Hsinlin T Cheng; Eva L Feldman
Journal:  Pharmacol Ther       Date:  2008-06-13       Impact factor: 12.310

8.  Effects of metoprolol on QT interval and QT dispersion in Type 1 diabetic patients with abnormal albuminuria.

Authors:  E Ebbehøj; H Arildsen; K W Hansen; C E Mogensen; H Mølgaard; P L Poulsen
Journal:  Diabetologia       Date:  2004-06-08       Impact factor: 10.122

Review 9.  QT interval, cardiovascular risk factors and risk of death in diabetes.

Authors:  M Veglio; A Chinaglia; P Cavallo-Perin
Journal:  J Endocrinol Invest       Date:  2004-02       Impact factor: 4.256

10.  Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus.

Authors:  Shigeki Nagamachi; Seigo Fujita; Ryuichi Nishii; Shigemi Futami; Shozo Tamura; Masanari Mizuta; Masamitsu Nakazato; Takeshi Kurose; Hideyuki Wakamatsu
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.